Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	-92.21	-625.03	8023.23
Graham Fair Price	4.66	71.52	68.34
PEG	16169.51	1.42	< 0.005
Price/Book	7.77	1.90	1.76
Price/Cash Flow	77.91	85.45	48.03
Prices/Earnings	3.03	10.38	10.07
Price/Sales	8.81	3.09	2.84
Price/FCF	77.91	85.45	48.03
Naive Interpretation	member

01 - Valuation · Weak

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	-10.52	0.89	1.00
Operating Margin	25189.59	0.10	< 0.005
ROA	7.90	< 0.005	< 0.005
ROE	0.04	0.05	4.60
ROIC	< 0.005	0.04	27924.97
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	< 0.005	< 0.005	-0.03
Dividends QOQ	0.04	< 0.005	-85.28
EBIT QOQ	-0.93	255.33	27449.12
EPS QOQ	11.54	0.07	-99.37
FCF QOQ	-0.59	-0.38	35.79
Revenue QOQ	< 0.005	0.01	50.47
Naive Interpretation	member

03 - Financial Growth · Positive

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	0.00	-1105.88	-100.00
Days Sales Outstanding (DSO)	221.23	216.97	-1.93
Inventory Turnover	0.00	-0.08	-100.00
Debt/Capitalization	0.24	0.24	-1.72
Quick Ratio	0.75	0.74	-1.12
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	68.86	70.47	2.33
Cash	21.92	20.71	-5.53
Capex	-0.06	-0.07	-18.18
Free Cash Flow	2.53	1.57	-38.01
Revenue	42.75	43.33	1.36
Naive Interpretation	member

05 - Per Share Metrics · Weak

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	0.42	0.42	-0.05
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	778.50	-61.04	-92.16
Naive Interpretation	Member

06 - Financial Health · Bad

Rating